|By PR Newswire||
|August 11, 2014 05:00 AM EDT||
NEW ORLEANS, Aug. 11 2014 /PRNewswire/ -- MT Services LLC, The Lawsuit Settlement News Reporting Company, reported today that there are still claims being filed, lawsuits being heard, and possible settlements discussions in the works, for patients of the reputed bad pharmaceutical drug Actos. With about 2,500 lawsuits filed in 2014 alone, and 4,000 active lawsuits taking place in State and Federal Courts of California, Illinois, and Louisiana, the Actos litigation remains in full swing. Takeda Pharmaceuticals and partner Eli Lily are fighting back to defend their company with post-trial motions and defending "Bellwether Trials" vigorously.
MT Services is here to assist patients and plaintiffs with Actos information, including providing them with case updates, lawsuit cash advances for patients with lawyers, and assistance with finding a credible Actos lawyer or Actos law firm to ascertain if they have a valid claim. Clients seeking lawsuit funding, must retain a law firm first.
To learn about MT Services' process and how we can help visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services
After the 2014 $9 billion verdict against Actos, manufactures Takeda Pharmaceuticals and Eli Lily are in the process of filing post-trial motion, alleging that the Louisiana court's punitive damages were awarded out of "passion and prejudice" and they have requested a new trial. The motion claims the company is entitled to a new review because the award was unconstitutional and excessive. This was the first bellwether case for Actos, while thousands of similar allegation cases are at hand in the courts.
For more information about the Actos litigation and how MTS can help, visit: http://www.lawsuitsettlementnews.com/actos-cases
Actos has been successful in turning some cases around; a post-trial motion in May of 2013 reversed a $6.5 million dollar verdict when a plaintiff's expert testimony was excluded in the state court. In September of 2013, when a plaintiff did not properly take care of his own health, under Maryland's contributory negligence law a defense verdict was reached. Most recently, a plaintiff's smoking history was a huge factor in whether or not Actos was at fault for the development of the plaintiff's bladder cancer. This resulted in the defense verdict as well, as seemingly the jury could not ascertain the causation link between the Cancer and either the smoking or use of the possible bad drug, Actos.
Chris Janish, CEO of LSN commented on the Actos Litigation, "Any drug with a connection to Cancer is one of the highest concerns. Unfortunately, many Actos plaintiffs were also smokers and this is what makes some of those cases tough to decide whether through trial or via a settlement. None the less, lawyers in our network are working vigorously to work through all these issues and get Actos patients that have been diagnosed with bladder cancer just compensation. The major verdict by the plaintiff counsel for $9 billion speaks volumes about the potential awards available in Actos cases with bladder cancer."
According to LSN, the Actos litigation can go either way, but thousands of cases are still pending in courts and verdicts and preliminary settlement discussions have taken place according to sources close to the litigation. However, due to the severity of the injuries and other obtaining factors, LSN cannot ascertain what the average settlement value could be if Takeda were to agree to a global settlement. "This is one litigation where the range of settlement values could be a wide range depending on many factors, it is simply too early to speculate ultimately who will win – Takeda or the plaintiffs – or if a settlement is reached what a plaintiff can expect at this time", added Mr. Janish.
MTS is providing lawsuit help including lawyer or law firm referrals for clients who request them, lawsuit cash advances (not to be considered lawsuit loans), surgical funding, and medical document retrieval for plaintiffs who need assistance getting medical records for their Actos potential litigation.
If you or a loved one has been injured by the Actos drug and need lawsuit help, including finding an Actos law firm, obtaining up to $50K in pre-settlement lawsuit funding, or obtaining surgical funding call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: lawsuitsettlementnews.com and an agent will contact you shortly.
Contact: Chris Janish, CEO
SOURCE MT Services LLC
Sep. 29, 2016 04:30 PM EDT Reads: 1,330
Sep. 29, 2016 04:30 PM EDT Reads: 1,928
Sep. 29, 2016 04:00 PM EDT Reads: 2,360
Sep. 29, 2016 04:00 PM EDT Reads: 439
Sep. 29, 2016 03:45 PM EDT Reads: 2,178
Sep. 29, 2016 03:30 PM EDT Reads: 1,612
Sep. 29, 2016 03:30 PM EDT Reads: 2,517
Sep. 29, 2016 03:15 PM EDT Reads: 1,769
Sep. 29, 2016 03:00 PM EDT Reads: 2,959
Sep. 29, 2016 03:00 PM EDT Reads: 2,760
Sep. 29, 2016 02:00 PM EDT Reads: 4,178
Sep. 29, 2016 02:00 PM EDT Reads: 1,145
Sep. 29, 2016 02:00 PM EDT Reads: 3,937
Sep. 29, 2016 02:00 PM EDT Reads: 3,600
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Sep. 29, 2016 01:45 PM EDT Reads: 1,116